Differential Discussions: Clinical Aspects of Type 1 VWD - The Fritsma Factor

Jan 16 2025

George Fritsma

Here is a follow-up to the 1-1-2025 Differential Discussion: VWD type 1 and the Ristocetin Cofactor Assay hosted by Malissa Norfolk and David Calder. Our second discussion is a brief overview entitled Clinical Aspects of Type 1 von Willebrand disease.

Comments (0)

Bleeding Disorders

No comments here.

Leave a Reply Cancel reply

You must be logged in to post a comment.

George Fritsma is a medical laboratory scientist, educator, and author. George holds faculty appointments with Rutgers University and Michigan State University, and is a member of the International Society on Thrombosis and Hemostasis, American Association of Clinical Chemists, and American Society for Clinical Laboratory Science.

Cheat Sheets from George

Quick Question